Secteur Arcturus Therapeutics Holdings Inc.

Actions

ARCT

US03969T1097

Recherche biotechnologique et médicale

Temps Différé Nasdaq 20:07:11 21/07/2026 Varia. 5j. Varia. 1 janv.
5,965 USD -0,08% Graphique intraday de Arcturus Therapeutics Holdings Inc. -6,30% -2,63%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
-0,08%-6,30%-17,44%-32,33%-2,63%-56,72%-82,36%-81,89% - 170 M
+0,88%-0,13%-4,50%+10,75%+6,05%+57,39%+54,58%+183,97%+5 933,33% 53,79 Md
+1,80%+5,16%+23,10%+26,75%+39,51%+53,09%+86,95%-23,57% - 54,69 Md
+1,44%-1,54%+9,95%-23,10%-37,71%+5,48%+414,30%+316,66%+870,59% 23,2 Md
+0,24%+2,13%+2,37%-17,27%-3,01%-15,22%-14,97%-64,44% - 23,31 Md
+1,46%+4,02%+25,96%+9,11%+23,47%+35,97%-4,03%-71,87% - 20,03 Md
+0,30%-0,40%+11,90%+6,96%-8,61%+33,13%-33,46%-33,34%+60,11% 17,31 Md
0,00%-6,00%+22,96%+98,09%+177,32%+163,95%+284,69%+1 545,53%+583,89% 14,99 Md
+1,49%+1,49%+23,02%+1,09%+30,42%+31,63%+654,98% - - 15,36 Md
+0,99%+0,43%+9,07%+22,05%+27,79%+26,55%+184,46%+228,89%+552,04% 13,96 Md
+1,72%+1,54%+6,29%+3,31%-6,39%+64,73%+152,68%+482,36% - 12,35 Md
+2,04%-1,57%+1,86%+22,55%+26,91%+118,18%+146,45%+175,41%+709,64% 10,74 Md
+7,07%-6,76%+1,02%-45,32%-17,52%-45,24%+621,25%+88,56%+101,75% 10,48 Md
+2,99%+2,78%-9,87%+4,03%+11,33%+402,45%+104,85%+8,56%+1 224,55% 10,09 Md
+1,34%-0,68%+8,05%-35,60%-16,28%-32,76%+164,99%+74,86% - 10,97 Md
+0,03%+0,23%+137,14%+115,68%+80,24%+171,08%+348,42%+324,81% - 8,84 Md
+5,47%+3,63%+2,22%+43,88%+213,02%+527,19%+591,47%-40,21%-9,65% 8,56 Md
+3,61%+2,21%+10,25%-5,12%+24,51%+61,20%+18,36%+143,54% - 8,01 Md
+1,73%+4,22%+24,38%-28,16%+18,33%+20,42%+103,34%-18,55% - 8,65 Md
+8,07%+2,47%+11,84%-0,31%+307,83%+201,31%+187,37%-31,63% - 7,85 Md
Moyenne +2,13%-2,49%+14,98%+8,85%+44,73%+91,19%+199,22%+168,83%+1 114,03% 16,67 Md
Moyenne pondérée par Capi. +1,72%-1,88%+13,71%+11,30%+31,93%+71,79%+170,02%+162,70%+2 316,21%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action ARCT
  4. Secteur Arcturus Therapeutics Holdings Inc.